» Articles » PMID: 34984007

Cut-off Points of Treatment Delay to Predict Poor Outcomes Among New Pulmonary Tuberculosis Cases in Dalian, China: A Cohort Study

Overview
Publisher Dove Medical Press
Date 2022 Jan 5
PMID 34984007
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Despite increasing literature on the association between treatment delay and outcomes, cut-off point (1 month or median) selection in almost all studies for treatment delay is too subjective. This study explored more scientific cut-off points of treatment delay for poor treatment outcomes and death at the clinical level.

Patients And Methods: A total of 18,100 newly confirmed pulmonary tuberculosis (TB) cases in Dalian, China were used in the final analysis. A 3-knotted restricted cubic spline (RCS) fitted for Cox proportional hazard regression models is used to analyse the effects of cut-off points of treatment delay on incident poor treatment outcomes. To explore the moderating effects of age, gender and diabetes, we added the interaction terms of these moderating variables and treatment delay to Cox proportional hazard regression models.

Results: The median time of treatment initiation was 30 days (IQR: 14-59 days). The risk of incident poor treatment outcomes increased when the time was greater than cut-off point 1 (53 days; adjusted HR: 1.26; 95% CI: 1.00-1.60) of treatment delay, and the risk of incident death events increased when the time was greater than cut-off point 2 (103 days; adjusted HR: 1.56; 95% CI: 1.00-2.44) of delay. In addition, treatment delay was associated with an increased risk of incident poor treatment outcomes and death, and older age, male sex, and diabetes may increase the risk of treatment delay for poor outcomes.

Conclusion: This study is the first to identify scientific cut-off points of treatment delay for poor treatment outcomes and death, and this method of exploration should be popularized. In addition, the knowledge of tuberculosis must be spread to every adult. Moreover, the tuberculosis diagnosis level of community level health workers should be enhanced.

Citing Articles

Interventions and implementation considerations for reducing pre-treatment loss to follow-up in adults with pulmonary tuberculosis: A scoping review.

Mulaku M, Owino E, Ochodo E, Young T F1000Res. 2025; 13:1436.

PMID: 39816981 PMC: 11733733. DOI: 10.12688/f1000research.157439.1.


Investigating the role of symptom valorisation in tuberculosis patient delay in urban areas in Portugal.

de Morais M, Sousa S, Marques J, Moniz M, Duarte R, Leite A BMC Public Health. 2023; 23(1):2421.

PMID: 38053129 PMC: 10696854. DOI: 10.1186/s12889-023-17319-7.


Drug Resistance Patterns and Trends in Patients with Suspected Drug-Resistant Tuberculosis in Dalian, China: A Retrospective Study.

Pan Y, Yu Y, Lu J, Yi Y, Dou X, Zhou L Infect Drug Resist. 2022; 15:4137-4147.

PMID: 35937782 PMC: 9348136. DOI: 10.2147/IDR.S373125.

References
1.
Gebreegziabher S, Bjune G, Yimer S . Total Delay Is Associated with Unfavorable Treatment Outcome among Pulmonary Tuberculosis Patients in West Gojjam Zone, Northwest Ethiopia: A Prospective Cohort Study. PLoS One. 2016; 11(7):e0159579. PMC: 4956157. DOI: 10.1371/journal.pone.0159579. View

2.
Dooley K, Chaisson R . Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009; 9(12):737-46. PMC: 2945809. DOI: 10.1016/S1473-3099(09)70282-8. View

3.
Asres A, Jerene D, Deressa W . Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study. BMC Pulm Med. 2018; 18(1):64. PMC: 5930812. DOI: 10.1186/s12890-018-0628-2. View

4.
Riccardi N, Alagna R, Motta I, Ferrarese M, Castellotti P, Nicolini L . Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges and future proposal. Infect Dis (Lond). 2019; 51(5):392-394. DOI: 10.1080/23744235.2019.1572920. View

5.
Ou Y, Luo Z, Mou J, Ming H, Wang X, Yan S . Knowledge and determinants regarding tuberculosis among medical students in Hunan, China: a cross-sectional study. BMC Public Health. 2018; 18(1):730. PMC: 5998553. DOI: 10.1186/s12889-018-5636-x. View